Medicamen Organics Limited (NSE:MEDIORG)
21.50
+1.00 (4.88%)
Jun 17, 2026, 11:38 AM IST
Medicamen Organics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 13.03 | 41.3 | 5.53 | 5.28 | 4.37 |
Cash & Short-Term Investments | 13.03 | 41.3 | 5.53 | 5.28 | 4.37 |
Cash Growth | -68.45% | 646.89% | 4.70% | 20.76% | -51.48% |
Accounts Receivable | 186.24 | 258.52 | 167 | 107.68 | 62.45 |
Receivables | 250.36 | 258.52 | 167 | 107.68 | 62.45 |
Inventory | 105.18 | 74.89 | 61.43 | 61.39 | 47.22 |
Prepaid Expenses | - | 0.54 | 0.44 | 1.09 | 1.17 |
Other Current Assets | - | 79.06 | 38.73 | 33.22 | 39.06 |
Total Current Assets | 368.56 | 454.32 | 273.12 | 208.66 | 154.28 |
Property, Plant & Equipment | 129.31 | 123.31 | 104.86 | 108.57 | 112.77 |
Long-Term Investments | - | 0.25 | 0.25 | 0.21 | 0.03 |
Goodwill | - | 0.01 | - | - | - |
Other Intangible Assets | 5.33 | 0.14 | 0.1 | 0.12 | 0.14 |
Long-Term Deferred Tax Assets | 0.99 | - | - | - | - |
Other Long-Term Assets | 12.09 | 14.05 | 6.08 | 8.3 | 8.16 |
Total Assets | 516.29 | 592.07 | 384.4 | 325.86 | 275.38 |
Accounts Payable | 55.56 | 117.03 | 70.8 | 89.99 | 73.09 |
Accrued Expenses | 2.27 | 9.17 | 8.05 | 6.23 | 4.68 |
Short-Term Debt | 132.48 | 120.57 | 123.3 | 111.54 | 91.84 |
Current Portion of Long-Term Debt | - | 1.39 | 1.65 | 3.15 | 4.21 |
Current Income Taxes Payable | - | 13.58 | 9.04 | 3.69 | 0.77 |
Other Current Liabilities | 27.19 | 9.82 | 3.36 | 4.4 | 0.83 |
Total Current Liabilities | 217.5 | 271.56 | 216.19 | 218.99 | 175.42 |
Long-Term Debt | 10.45 | 1.58 | 1.61 | 3.26 | 6.41 |
Pension & Post-Retirement Benefits | - | 2.08 | 1.75 | 1.72 | 1.89 |
Long-Term Deferred Tax Liabilities | - | 11.6 | 11.85 | 11.65 | 11.14 |
Other Long-Term Liabilities | 2.48 | 0.45 | 0.4 | 0.44 | 0.41 |
Total Liabilities | 230.42 | 287.27 | 231.81 | 236.06 | 195.27 |
Common Stock | 121.66 | 117 | 86 | 60 | 60 |
Additional Paid-In Capital | - | 95.54 | 21.14 | 9.14 | 9.14 |
Retained Earnings | - | 81.25 | 45.45 | 20.66 | 10.96 |
Comprehensive Income & Other | 165.61 | 7.5 | - | - | - |
Total Common Equity | 287.27 | 301.29 | 152.59 | 89.8 | 80.11 |
Minority Interest | -1.41 | 3.51 | - | - | - |
Shareholders' Equity | 285.87 | 304.81 | 152.59 | 89.8 | 80.11 |
Total Liabilities & Equity | 516.29 | 592.07 | 384.4 | 325.86 | 275.38 |
Total Debt | 142.93 | 123.53 | 126.57 | 117.95 | 102.46 |
Net Cash (Debt) | -129.9 | -82.23 | -121.04 | -112.67 | -98.08 |
Net Cash Per Share | -11.02 | -7.44 | -16.00 | -18.78 | -16.35 |
Filing Date Shares Outstanding | 11.86 | 11.7 | 8.6 | 6 | 6 |
Total Common Shares Outstanding | 11.86 | 11.7 | 8.6 | 6 | 6 |
Working Capital | 151.07 | 182.76 | 56.93 | -10.33 | -21.14 |
Book Value Per Share | 24.22 | 25.75 | 17.74 | 14.97 | 13.35 |
Tangible Book Value | 281.94 | 301.15 | 152.49 | 89.68 | 79.97 |
Tangible Book Value Per Share | 23.77 | 25.74 | 17.73 | 14.95 | 13.33 |
Land | - | 6.19 | 6.19 | 5.37 | 5.37 |
Buildings | - | 54.56 | 54.56 | 47.96 | 47.84 |
Machinery | - | 122.06 | 118.35 | 113.31 | 110.55 |
Construction In Progress | - | 22.16 | 1.46 | - | - |